biotech

Flagship raises $1.1B to create biotechs for post-pandemic world
Flagship raises $1.1B to create biotechs for post-pandemic world
Fierce Biotech
Flagship Pioneering
biotech
COVID-19
pandemic
Flag link:
This Biotech Startup Is Out To Change How Drugs Are Prescribed
This Biotech Startup Is Out To Change How Drugs Are Prescribed
Forbes
biotech
Olaris
biomarkers
startups
Flag link:
Takeda signs $882m rare disease alliance with Oxford biotech Evox
Takeda signs $882m rare disease alliance with Oxford biotech Evox
Pharmaforum
Evox Therapeutics
Takeda
Rare Diseases
biotech
Flag link:
Biotech’s balancing act amid Covid-19 delays
Biotech’s balancing act amid Covid-19 delays
EP Vantage
R&D
COVID-19
biotech
Flag link:
Strategic Planning In Biotech During A Pandemic Crisis
Strategic Planning In Biotech During A Pandemic Crisis
Forbes
biotech
R&D
strategic planning
COVID-19
Flag link:
What it’s like to go into the lab at a biopharma company during the coronavirus pandemic
What it’s like to go into the lab at a biopharma company during the coronavirus pandemic
Stat
lab workers
biopharma
biotech
COVID-19
coronaviruses
Flag link:
Biotech IPO market sealed shut for the foreseeable future: report
Biotech IPO market sealed shut for the foreseeable future: report
Fierce Biotech
biotech
IPOs
COVID-19
Flag link:
In hard-hit Seattle, coronavirus pushes biotechs to a new normal
In hard-hit Seattle, coronavirus pushes biotechs to a new normal
BioPharma Dive
Seattle
biotech
COVID-19
Flag link:
Can This American Biotech Company Save the Global Economy?
Can This American Biotech Company Save the Global Economy?
Motley Fool
Gilead Sciences
remdesivir
COVID-19
biotech
coronaviruses
Flag link:
Top 10 biotech IPOs in 2019
Top 10 biotech IPOs in 2019
Fierce Biotech
biotech
IPOs
Flag link:
Biotech executives, having pledged fair pricing, criticize drugmaker for steep hike
Biotech executives, having pledged fair pricing, criticize drugmaker for steep hike
BioPharma Dive
biotech
injectibles
drug pricing
Belcher Pharmaceuticals
Flag link:
Dutch biotech sector feel benefits of EMA move, says industry leader
Dutch biotech sector feel benefits of EMA move, says industry leader
Pharmaforum
EMA
Europe
The Netherlands
Brexit
biotech
Flag link:
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Flag link:
Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies
Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies
Endpoints
biotech
bankruptcy
Flag link:
BIO Report: More Work Needed to Improve Diversity at Biotech Firms
BIO Report: More Work Needed to Improve Diversity at Biotech Firms
Xconomy
diversity
biotech
Flag link:
Three star scientists announce plan to solve biotech’s ‘missing women’ problem
Three star scientists announce plan to solve biotech’s ‘missing women’ problem
Stat
biotech
women
women executives
Boston Biotech Working Group
Flag link:
Wither New Biotech Startups?
Wither New Biotech Startups?
Forbes
biotech
start-ups
Flag link:
I Have a Dream… Five Dreams for Biotech
I Have a Dream… Five Dreams for Biotech
BioSpace
biotech
patients
Alzheimer's disease
ALS
HIV
cancer
drug pricing
Flag link:
5 biotech trends to follow in 2020
5 biotech trends to follow in 2020
BioPharma Dive
biotech
M&A
drug launches
JPMHC 2020
Flag link:
Fear and loathing in Union Square: Upcoming biotech conference exposes industry dreams, issues
Fear and loathing in Union Square: Upcoming biotech conference exposes industry dreams, issues
Bizjournals
JPMHC 2020
San Francisco
biotech
Flag link:

Pages